These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3693298)

  • 21. Serogroup prevalence of Shigellae in Bombay.
    Sonawala M; Saraswathi K; Deodhar LP
    J Postgrad Med; 1995; 41(4):104-6. PubMed ID: 10707731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of bacillary dysentery with Wintomylon].
    Ishikawa J
    Nihon Densenbyo Gakkai Zasshi; 1967 Mar; 40(12):460-2. PubMed ID: 4962909
    [No Abstract]   [Full Text] [Related]  

  • 23. Randomized clinical trial of norfloxacin for shigellosis.
    Bhattacharya SK; Bhattacharya MK; Dutta P; Sen D; Rasaily R; Moitra A; Pal SC
    Am J Trop Med Hyg; 1991 Dec; 45(6):683-7. PubMed ID: 1763794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dysentery in Nicaragua.
    Vijil C
    N Engl J Med; 1972 Jan; 286(2):106-7. PubMed ID: 5006868
    [No Abstract]   [Full Text] [Related]  

  • 25. Nalidixic acid for shigellosis.
    McCormack JG
    Lancet; 1983 Nov; 2(8358):1091. PubMed ID: 6138641
    [No Abstract]   [Full Text] [Related]  

  • 26. Epidemic dysentery caused by Shigella dysenteriae type 1: a sentinel site surveillance of antimicrobial resistance patterns in Burundi.
    Engels D; Madaras T; Nyandwi S; Murray J
    Bull World Health Organ; 1995; 73(6):787-91. PubMed ID: 8907772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of pivmecillinam and nalidixic acid in the treatment of acute shigellosis in children.
    Alam AN; Islam MR; Hossain MS; Mahalanabis D; Hye HK
    Scand J Gastroenterol; 1994 Apr; 29(4):313-7. PubMed ID: 8047805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Double-blind comparison of oral gentamicin and nalidixic acid in the treatment of acute shigellosis in children.
    Islam MR; Alam AN; Hossain MS; Mahalanabis D; Hye HK
    J Trop Pediatr; 1994 Dec; 40(6):320-5. PubMed ID: 7853434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapy for shigellosis. I. Randomized, double-blind trial of nalidixic acid in childhood shigellosis.
    Salam MA; Bennish ML
    J Pediatr; 1988 Nov; 113(5):901-7. PubMed ID: 3054035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Controlled comparison of nalidixic acid or lactulose with placebo in shigellosis.
    Hansson HB; Barkenius G; Cronberg S; Juhlin I
    Scand J Infect Dis; 1981; 13(3):191-3. PubMed ID: 7031858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative efficacy of furazolidone and nalidixic acid in the empirical treatment of acute invasive diarrhea: randomized clinical trial.
    Dutta P; Sett A; Sarkar A; Mitra U; Saha D; Manna B; Kundu B; Gupta A
    Indian Pediatr; 1995 Jan; 32(1):13-9. PubMed ID: 8617528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nalidixic acid is still the drug of choice for shigellosis in Pakistan.
    Mahmood A
    J Pak Med Assoc; 2001 Feb; 51(2):101. PubMed ID: 11321869
    [No Abstract]   [Full Text] [Related]  

  • 33. Drugs for dysentery.
    Br Med J; 1970 Apr; 2(5700):36-7. PubMed ID: 5443981
    [No Abstract]   [Full Text] [Related]  

  • 34. [An outbreak of Shigella dysenteriae type 1 dysentery in a refugee camp in Rwanda].
    Paquet C; Leborgne P; Sasse A; Varaine F
    Sante; 1995; 5(3):181-4. PubMed ID: 7640901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Drug-resistant dysentery].
    Saito M
    Naika; 1965 Jul; 16(1):62-5. PubMed ID: 5884584
    [No Abstract]   [Full Text] [Related]  

  • 36. Multidrug resistant Shigella infections in children.
    Patwari AK
    J Diarrhoeal Dis Res; 1994 Sep; 12(3):182-6. PubMed ID: 7868824
    [No Abstract]   [Full Text] [Related]  

  • 37. [Drug-resistant dysentery].
    Suzuki Y
    Naika; 1970 Jun; 25(6):1155-6. PubMed ID: 5431257
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of antimicrobial (nalidixic acid) therapy in shigellosis and predictive values of outcome variables in patients susceptible or resistant to it.
    Islam MR; Alam AN; Hussain MS; Mahalanabis D
    J Trop Med Hyg; 1995 Apr; 98(2):121-5. PubMed ID: 7714935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Death from multi-resistant shigelloses: a case study from Fiji.
    Watson C
    Pac Health Dialog; 2006 Sep; 13(2):111-4. PubMed ID: 18181399
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Results in the combined use of nalidixic acid with other drugs for bacillary dysentery].
    Sugano T; Tashiro F; Matsumoto T
    Nihon Densenbyo Gakkai Zasshi; 1967 Oct; 41(7):256-67. PubMed ID: 4968896
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.